Lali's Law

Summary

Lali's Law This bill amends the Public Health Service Act to permit the Centers for Disease Control and Prevention to make grants to states that allow standing orders (documents that allow a person to acquire, dispense, or administer a prescription medication without a person-specific prescription) for opioid overdose reversal medication (e.g., naloxone). (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.) Grants may be used for: developing standing orders for opioid overdose reversal medication for pharmacies; encouraging pharmacies to dispense medication pursuant to such a standing order; implementing guidelines and best practices for prescribing opioids, prescribing opioid overdose reversal medication with opioids, and discussing opioid overdose reversal medication with patients; developing training for prescribers to use in educating the public on administration of opioid overdose reversal medication; and educating the public on the availability and public health benefits of opioid overdose reversal medication. States must report on pharmacies that dispense opioid overdose reversal medication under a standing order and the number of pharmacists trained in educating the public on administration of opioid overdose reversal medication.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

11 official files

• Referred in Senate (text)

  Referred in Senate · EN · 16 May 2016

  ViewDownloadOpen at official source

• Referred in Senate (PDF)

  Referred in Senate · EN · 16 May 2016

  ViewDownloadOpen at official source

• Engrossed in House (text)

  Engrossed in House · EN · 12 May 2016

  ViewDownloadOpen at official source

• Engrossed in House (PDF)

  Engrossed in House · EN · 12 May 2016

  ViewDownloadOpen at official source

• Passed House amended

  summary · EN · 12 May 2016

  Open at official source

• Reported in House (text)

  Reported in House · EN · 10 May 2016

  ViewDownloadOpen at official source

• Reported in House (PDF)

  Reported in House · EN · 10 May 2016

  ViewDownloadOpen at official source

• Reported to House with amendment(s)

  summary · EN · 10 May 2016

  Open at official source

• Introduced in House (text)

  Introduced in House · EN · 23 February 2016

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 23 February 2016

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 23 February 2016

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.